Skip to main content
. 2022 Oct 31;17(1):1724–1741. doi: 10.1515/med-2022-0585

Figure 9.

Figure 9

The expression of ASAP3 and NOTCH3 in LGG and their relationship with prognosis. (a) Patients with high ASAP3 expression have a significantly shorter survival time (P < 0.0001). (b) Patients with high NOTCH3 expression have a significantly shorter survival time (P = 0.0009). (c) Patients with high co-expressions of ASAP3 and NOTCH3 have a shorter OS time (P < 0.0001).